Tasosartan: Difference between revisions

Tasosartan
Clinical data
ATC code	C09CA05 (WHO) ;
Identifiers
	IUPAC name 2,4-dimethyl-8-[ [4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-5,6-dihydropyrido[6,5-d]pyrimidin-7-one;
PubChem CID	60919;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C23H21N7O
Molar mass	411.459 g/mol

VisualWikitext

Revision as of 18:21, 27 September 2011

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Tasosartan is an angiotensin II receptor antagonist.

Template:Agents acting on the renin-angiotensin system Template:SIB

Template:WikiDoc Sources

Revision as of 17:30, 10 June 2009 (view source) Brian Blank (talk \| contribs) No edit summary	Revision as of 18:21, 27 September 2011 (view source) WikiBot (talk \| contribs) m (Protected "Tasosartan": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) Newer edit →
(No difference)

Clinical data

ATC code	C09CA05 (WHO)
Identifiers
IUPAC name 2,4-dimethyl-8-[ [4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-5,6-dihydropyrido[6,5-d]pyrimidin-7-one
PubChem CID	60919
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₃H₂₁N₇O
Molar mass	411.459 g/mol

Tasosartan: Difference between revisions

Revision as of 18:21, 27 September 2011

Overview

Navigation menu